These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21605180)

  • 1. Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.
    Schulz B; Weber K; Schmidt A; Borg-von Zepelin M; Ruhnke M
    Mycoses; 2011 Sep; 54(5):e522-30. PubMed ID: 21605180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
    Reynes J; Mallie M; Ravisse P; Bastide JM
    J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adherence of isolated Candida albicans strains from HIV+ infected patients to buccal epithelial cells: correlation with serotype, sensitivity to fluconazole and virulence].
    Imbert-Bernard C; Valentin A; Reynes J; Mallié M; Bastide JM
    Pathol Biol (Paris); 1994 Jun; 42(6):567-73. PubMed ID: 7854856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
    Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW
    J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance genes and trailing growth in Candida albicans isolates.
    Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
    J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
    Ribeiro MA; Paula CR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
    González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E
    Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
    Morio F; Pagniez F; Lacroix C; Miegeville M; Le Pape P
    J Antimicrob Chemother; 2012 Sep; 67(9):2131-8. PubMed ID: 22678731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.
    Schulz B; Knobloch M; Weber K; Ruhnke M
    Int J Med Microbiol; 2012 Jul; 302(3):155-61. PubMed ID: 22664377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluconazole treatment of mice infected with fluconazole-susceptible and -resistant Candida tropicalis on fungal cell surface hydrophobicity, adhesion and biofilm formation.
    Kanoshiki RL; de Paula SB; Santos JP; Morey AT; Souza NB; Yamauchi LM; Dias Filho BP; Yamada-Ogatta SF
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():97-101. PubMed ID: 25657165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on experimental induction of fluconazole resistance in Candida albicans].
    Zhu YN; Lu SM
    Shi Yan Sheng Wu Xue Bao; 2004 Oct; 37(5):418-22. PubMed ID: 15636370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
    Zore GB; Thakre AD; Rathod V; Karuppayil SM
    Mycoses; 2011 Jul; 54(4):e99-109. PubMed ID: 20337938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
    J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between phospholipase of Candida albicans and resistance to fluconazole.
    Ying S; Chunyang L
    Mycoses; 2012 Jan; 55(1):50-5. PubMed ID: 21623950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
    J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y; Chen L; Li C
    J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.